Search - tctmd.com

Displaying 141 - 160 of 181

Sort: Relevancy | Date

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Conference News EuroPCR 2015

Evolving DES Technology May Benefit Diabetic Patients

Caitlin E. Cox

May 19, 2015

News Daily News

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

L.A. McKeown

April 03, 2015

News Daily News

XAMI at 3 Years: Rates of Very Late Stent Thrombosis Similarly Low for EES, SES in Acute MI Patients

L.A. McKeown

January 29, 2015

News Daily News

XAMI a los 3 Años: Similares Índices Bajos de Trombosis Muy Tardía del Stent para SLE, SLS y Pacientes que sufren IAM

L.A. McKeown

January 29, 2015

News Daily News

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

L.A. McKeown

November 02, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Conference News EuroPCR 2014

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Caitlin E. Cox

May 21, 2014

News Conference News EuroPCR 2014

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Caitlin E. Cox

May 20, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Conference News TCT 2013

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

October 30, 2013

Presentation TCT 2013

Everolimus-eluting Stents in Left Main Disease: The ULMD Florence PCI Registry (with Angiographic Follow-up)

Presenter: David Antoniucci

October 28, 2013

Presentation TCT 2013

Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results

Presenter: Young-Hak Kim

October 28, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Daily News

BBC ONE: Simple, Complex Bifurcation Stenting Both Improve QoL

L.A. McKeown

February 24, 2013

Presentation TCT 2012

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Presenter: Julinda Mehilli

October 24, 2012

Advertisement

COMPARE: EES Maintains Advantage Over PES at 5 Years

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Evolving DES Technology May Benefit Diabetic Patients

Korean Registry Shows PCI Increasingly Used for Left Main Disease, With Improving Outcomes

XAMI at 3 Years: Rates of Very Late Stent Thrombosis Similarly Low for EES, SES in Acute MI Patients

XAMI a los 3 Años: Similares Índices Bajos de Trombosis Muy Tardía del Stent para SLE, SLS y Pacientes que sufren IAM

TWENTE: Second-Generation DES Show Good Long-term Outcomes in Bifurcation Lesions

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

BABILON: Drug-Eluting Balloon a Risky Choice for Treating Bifurcation Lesions

Despite Some Good News, Dedicated Stents Fail to Surpass Standard Care for Bifurcation Lesions

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

Everolimus-eluting Stents in Left Main Disease: The ULMD Florence PCI Registry (with Angiographic Follow-up)

Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results

SES Show Advantage Over ZES, PES for Diabetic Patients

BBC ONE: Simple, Complex Bifurcation Stenting Both Improve QoL

ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content